SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

MoonLake Reports Third-Quarter 2026 Results and Business Update

MoonLake Immunotherapeutics reported third-quarter 2026 financial results and provided a business update.

MLTX
SquawkNews Desk 1 updates Updated Nov 04, 2026, 12:18 PM UTC

Story updates

12:18:44 PM UTC
SquawkNews
MoonLake Q3 R&D expenses rise 37% quarter over quarter to $68.9 million MoonLake’s third-quarter

Related stories

NHPC Q2 consolidated revenue from operations at 44.83 billion rupees M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC MGE Energy Reports Q3 2026 Operating Revenue of $190.4 Million M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC US Equity Futures Rise Pre-Bell as Traders Assess Midterm Election Results US equity futures rose before the bell as traders assessed the implications of a Democratic win in the US midterm elections. M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC NHPC Reports Q2 Consolidated Net Profit of 15.49 Billion Rupees M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC Pliant Raises $80 Million in Series C Funding Seaya Nova and Speedinvest led the oversubscribed round. Pliant is opening its commercial payments infrastructure to AI agents. L impact | EQUITY | Nov 04, 2026, 01:59 PM UTC Kyndryl Q2 Adjusted Earnings Rise as Revenue Falls; Reaffirms 2026 Outlook Kyndryl reported higher adjusted earnings and lower revenue for Q2, and reaffirmed its 2026 revenue outlook. M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC